another way to raise the $10mill to last through fda response might be a rights offering to present shareholders..eg right to purchase 2/3 share per share owned @ say .35 would raise (46mill sh x .667 x $.35 = $10.7mill) would be feasible if some institution were willing to kick in for any unexercised rights to fill the offering. Although this would dilute total shares, at least each shareholder would have the option to maintain his or her present % stake in the company by participating in offering. maybe also officers should be required to purchase shares to match their options.:)
Market Data 
Markets 
AI
